SImBA-SiQuAl: advancing high-content high-throughput phenotypic profiling of 3D microtumours
Preprint
Abstract
SUMMARY: Three-dimensional microtumour models such as spheroids are increasingly used in cancer research as they better capture tumour architecture, growth and invasion than conventional two-dimensional cultures. However, robust and accessible tools for quantitative analysis remain limited. Here we present SImBA-SiQuAl, an integrated open-source workflow for high-throughput quantitative phenotyping of 3D spheroids and organoids. The pipeline combines SImBA, an automated image-analysis framework for performant quality-controlled image segmentation and multi-feature extraction from spheroid assays, with SiQuAl, a downstream analysis platform that automatically performs comprehensive statistical and multivariate analyses to reveal phenotypic differences between experimental conditions. In a first case study, we showcase how SImBA-SiQuAl resolves intrinsic invasion phenotypes between cancer cell lines. In a second case study, it quantifies heterogeneous responses in a spheroid drug screening assay. Together, SImBA-SiQuAl provides an effective timely tool for high-throughput, high-content microtumour phenomics in cancer research. MOTIVATION: 3D-microtumour assays such as spheroids and organoids are increasingly used in preclinical research. These assays generate rich phenotypic imaging data, but automated quantitative analysis remains a major bottleneck. This limits reproducibility, scalability, and broad adoption for large-scale, high-content phenomics studies. Moreover, it impedes comprehensively addressing biologically relevant phenotypic (heterogeneous) responses in e.g. perturbation studies. SImBA-SiQuAl ( S pheroid Im age B atch A nalysis - Si mba Qu antitative output A na l ysis) is developed to address this gap by providing an open-source, integrated workflow offering solutions in both the image processing and downstream analysis. Together, this enables in-depth quantitative analysis of 3D microtumour phenotypes across experimental settings.Keywords
Funding Information
- UGent Bijzonder Onderzoeksfonds (BOF.BAF.2024.0285.01)
This publication has 88 references indexed in Scilit:
- CCDC137 affects sorafenib resistance in hepatocellular carcinoma cells by activating the AKT/mTOR signaling pathwayClinical and Translational Oncology, 2026
- A single-cell derived spheroid approach to dissect intratumoural heterogeneity in colorectal cancer: cell lines show changes in proteomes and therapeutic response to 5-FUJournal of Cancer Research and Clinical Oncology, 2026
- A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicineCellular Oncology, 2024
- Relatively Rare Populations of Invasive Cells Drive Progression of Heterogeneous TumorsCellular and Molecular Bioengineering, 2024
- A comprehensive review of 3D cancer models for drug screening and translational researchCancer Innovation, 2023
- Recent Advances on Cell Culture Platforms for In Vitro Drug Screening and Cell Therapies: From Conventional to Microfluidic StrategiesAdvanced Healthcare Materials, 2023
- Pancreatic Cancer Presents Distinct Nanomechanical Properties During ProgressionAnnals of Biomedical Engineering, 2023
- Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncologyActa Neuropathologica, 2020
- Analysis of Invasion Dynamics of Matrix-Embedded Cells in a Multisample Format2018
- INSIDIA: A FIJI Macro Delivering High‐Throughput and High‐Content Spheroid Invasion AnalysisBiotechnology Journal, 2017